Breaking Stories

: CureVac’s COVID vaccine candidate 47% effective, stock tanks

0

Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness.

Key Words: The lure of the open road — and the open-air hotel corridor

Previous article

Key Words: The lure of the open road — and the open-air hotel corridor

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *